Event Event

HBV 2024

September 11 - September 15, 2024

Chicago, Ill.

Register

The HBV International Meeting will be held September 11-15 in Chicago, IL. Join Parexel at this influential event that will boast a content-packed agenda on cutting-edge studies in hepatitis B and D viruses (HBV and HDV) along with the development of new technologies and analytical methods for understanding HBV and HDV infection.

Take the additional opportunity to join Parexel's expert speakers on Thursday, Sept 12 as we discuss "Turning molecules into medicines through a stepwise, strategic and collaborative approach".  The panel discussion will explore how patient insights drive innovation, improve trial design, and shape research priorities in the fight against Hepatitis B. The panel will discuss current challenges in Hepatitis B research and treatment and how increased patient engagement and collaboration can help overcome these obstacles. 

Panelists will share insights on how patient engagement across all phases of research is key to propel progress in finding the cure for Hepatitis B!

Learn more how patients will reshape the future of Hepatitis B research and treatment: 

The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure

Be Heppy Podcast 

Wendy’s Journey as a Hepatitis B Patient Advocate

Hepatitis B Foundation’s The Voice of the Patient Report: Living with Chronic Hepatitis B

Attitudes towards Clinical Trial Participation among People Living with Chronic Hepatitis B

Applying Patient and Public Involvement in preclinical research: A co-created scoping review

Automated data collection tool for real-world cohort studies of chronic hepatitis B: Leveraging OCR and NLP technologies for improved efficiency - ScienceDirect


Parexel speakers:

Anne Kasmar, M.D., M.Sc.

Senior Vice President, Global Therapeutic Area Head, Infectious Disease & Vaccines

Thursday, Sept. 12 (timing pending)
Title – "Turning molecules into medicines through a stepwise, strategic and collaborative approach."

Roger Inouye, M.D.

Senior Medical Director

Thursday, Sept. 12 (timing pending)
Title – "Turning molecules into medicines through a stepwise, strategic and collaborative approach."